As of 2026-09-11, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.40 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-07-03 | -0.05 |
| 2026-07-02 | -0.05 |
| 2026-06-30 | -0.04 |
| 2026-06-26 | -0.04 |
| 2026-06-25 | -0.04 |
| 2026-06-24 | -0.04 |
| 2026-06-23 | -0.04 |
| 2026-06-22 | -0.04 |
| 2026-06-17 | -0.04 |
| 2026-06-16 | -0.04 |
| 2026-06-15 | -0.04 |
| 2026-06-12 | -0.04 |